DarioHealth (NASDAQ:DRIO) Stock Passes Below 200-Day Moving Average – What’s Next?

DarioHealth Corp. (NASDAQ:DRIO) crossed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $11.68 and traded as low as $11.00. DarioHealth shares last traded at $11.25, with a volume of 7,322 shares trading hands.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on the stock. Wall Street Zen lowered shares of DarioHealth from a “hold” rating to a “sell” rating in a report on Sunday, January 25th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of DarioHealth in a research report on Monday, December 29th. Stifel Nicolaus set a $16.00 price objective on DarioHealth in a research note on Friday, November 14th. Finally, TD Cowen reiterated a “hold” rating on shares of DarioHealth in a report on Friday, November 14th. Two analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, DarioHealth has an average rating of “Hold” and an average target price of $38.00.

DarioHealth Stock Performance

The stock’s 50-day simple moving average is $11.42 and its 200 day simple moving average is $11.68. The company has a market capitalization of $76.05 million, a PE ratio of -1.01 and a beta of 1.16. The company has a debt-to-equity ratio of 0.41, a quick ratio of 4.02 and a current ratio of 4.55.

Institutional Investors Weigh In On DarioHealth

A hedge fund recently raised its stake in DarioHealth stock. XTX Topco Ltd increased its holdings in shares of DarioHealth Corp. (NASDAQ:DRIO) by 229.0% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 62,511 shares of the company’s stock after purchasing an additional 43,513 shares during the quarter. XTX Topco Ltd owned approximately 0.14% of DarioHealth worth $42,000 at the end of the most recent quarter. Hedge funds and other institutional investors own 33.39% of the company’s stock.

DarioHealth Company Profile

DarioHealth (NASDAQ:DRIO) is a digital health company specializing in chronic disease management through a smartphone-based care platform. Its core solution combines connected devices—such as glucose meters, blood pressure monitors and smart scales—with real-time data analytics and personalized coaching. The platform is designed to support individuals living with diabetes, hypertension, weight management challenges and other cardiometabolic conditions, offering continuous monitoring, tailored insights and behavioral nudges aimed at improving clinical outcomes.

The Dario platform integrates artificial intelligence and machine learning to deliver personalized guidance and education.